Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma

Catriona A. Ford, Sofia Petrova, John D. Pound, Jorine J.L.P. Voss, Margaret Paterson, Sarah L. Farnworth, Awen M. Gallimore, Simone Cuff, Helen Wheadon, Edwina Dobbin, Carol Anne Ogden, Ingrid E. Dumitriu, Donald R. Dunbar, Paul G. Murray, Dominik Ruckerl, Judith E. Allen, David A. Hume, Nico van Rooijen, John R. Goodlad, Tom C. FreemanChristopher D. Gregory*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Cells undergoing apoptosis are known to modulate their tissue microenvironments. By acting on phagocytes, notably macrophages, apoptotic cells inhibit immunological and inflammatory responses and promote trophic signaling pathways. Paradoxically, because of their potential to cause death of tumor cells and thereby militate against malignant disease progression, both apoptosis and tumor-associated macrophages (TAMs) are often associated with poor prognosis in cancer. We hypothesized that, in progression of malignant disease, constitutive loss of a fraction of the tumor cell population through apoptosis could yield tumor-promoting effects. Results: Here, we demonstrate that apoptotic tumor cells promote coordinated tumor growth, angiogenesis, and accumulation of TAMs in aggressive B cell lymphomas. Through unbiased "in situ transcriptomics" analysis-gene expression profiling of laser-captured TAMs to establish their activation signature insitu-we show that these cells are activated tosignal via multiple tumor-promoting reparatory, trophic, angiogenic, tissue remodeling, and anti-inflammatory pathways. Our results also suggest that apoptotic lymphoma cells help drive this signature. Furthermore, we demonstrate that, upon induction of apoptosis, lymphoma cells not only activate expression of the tumor-promoting matrix metalloproteinases MMP2 and MMP12 in macrophages but also express and process these MMPs directly. Finally, using a model of malignant melanoma, we show that the oncogenic potential of apoptotic tumor cells extends beyond lymphoma. Conclusions: In addition to its profound tumor-suppressive role, apoptosis can potentiate cancer progression. These results have important implications for understanding the fundamental biology of cell death, its roles in malignant disease, and the broader consequences of apoptosis-inducing anti-cancer therapy. Apoptosis and tumor-associated macrophages (TAMs) are often associated with poor prognosis in cancer. Ford etal. demonstrate apoptotic lymphoma cells can promote tumor growth, angiogenesis, TAM accumulation, and TAM activation to potentiate cancer progression. These results have important implications for apoptosis-inducing anti-cancer therapies.

Original languageEnglish
Pages (from-to)577-588
Number of pages12
JournalCurrent Biology
Volume25
Issue number5
Early online date19 Feb 2015
DOIs
Publication statusPublished - 2 Mar 2015

Fingerprint

Dive into the research topics of 'Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma'. Together they form a unique fingerprint.

Cite this